The goal of the Academic Drug Discovery Consortium (ADDC) is to build a collaborative network among the growing number of university-led drug discovery centers and programs. With this interactive website, we aim to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. It is with the active participation of each ADDC member that this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of our members will enable the ADDC to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs.
The Molecular Screening Shared Resource (MSSR) offers a comprehensive range of high throughput screening (HTS) services including chemical genomics, functional genomics and drug discovery. The MSSR is an open environment and welcomes academic investi...View all
UCB as agreed to fund and support a third research project called "Mining the Human Microbiome" as part of the UCB-Harvard Research Alliance. UCB will be providing $4.5 million over a period of three years to immunologists at Harvard to study the ...View all
Diabetic Kidney Disease: Drug Discovery and Clinical Development Challenges
09 December, 2014
Circulating Biomarkers World Congress
23 March, 2015